CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 126 enrolled
Drug / intervention
Text messages +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01569243
NCT01569243Phase 2Completed
CompareCT.gov

Using Activity Monitoring and Text Messaging For Behavior Change in a Diabetes Self-Management Program

Massachusetts General Hospital·interventional·Posted Apr 3, 2012·Updated Sep 1, 2020

In Brief

A Phase 2 clinical trial evaluating Text messages and Usual care for Type 2 Diabetes Mellitus. Completed, enrolled 126 participants across 2 sites.

Detailed Summary

This study is a 2-arm randomized controlled trial examining the effect of personalized text messages on physical activity and clinical outcomes in patients with type 2 diabetes mellitus. The investigators hypothesize that: i. The use of personalized text messages will promote physical activity in patients with T2DM. ii. Increased physical activity and behavior change correlate with better clinical outcomes (Change in HbA1c). iii. The text messaging program will lead to sustained physical activity behavior change in patients with T2DM

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
CountriesUnited States
CollaboratorsMcKesson Foundation

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 3, 2012
Enrollment StartJun 1, 2012
Primary CompletionOct 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 14.2 years ago

Interventions

Text messagesother

* Participants will receive diabetic medical care as usual. * Participants will be given an ActiHealth pedometer to measure daily activity. * In addition, they will be enrolled to receive the study text messages.

Usual careother

* Participants will receive diabetic medical care as usual. * In addition, participants in the control group will be given an ActiHealth pedometer to measure daily activity (step counts will be used as a proxy for activity).